People

Hovione has named Mike Ironside as General Manager of its Technology Transfer Center (TTC), which is located in New Jersey. Ironside was most recently with Anacor Pharmaceuticals and has previously worked for GSK and AMRI. Hovione VP of Corporate R&D Thomas Eisele said, "This is a key appointment at an important time for Hovione. We are certain that Dr. Ironside's … [Read more...] about Hovione appoints new General Manager of its Technology Transfer Center

Particle manufacturing specialist Liquidia Technologies has named Benjamin Yerxa, most recently at Clearside Biomedical, as its new Chief Scientific Officer. Yerxa will oversee R&D, "including a focus on scientific collaborations," for the company. Liquidia's PRINT nanofabrication technology can produce particles of specified sizes and shapes for inhalation powders … [Read more...] about Liquidia hires Benjamin Yerxa as Chief Scientific Officer

Hovione has announced the appointment of Conrad Winters as Director, Drug Product Development. Winters most recently was Senior Director of the Compound Properties Group at Xenon Pharmaceuticals and previously held positions with Merck. Hovione VP of Corporate Research & Development Thomas Eisele commented, "We are very pleased to welcome Dr. Winters to Hovione. … [Read more...] about Hovione hires Conrad Winters as Director of Drug Product Development

Inhaled drug company Alexza Pharmaceuticals has announced the promotions of four executives. The company has promoted James V. Cassella to Executive VP, Research and Development and Chief Scientific Officer; Darl Moreland to Senior VP, Quality; Mark K. Oki to Senior VP, Finance and Chief Financial Officer; and Edwin S. Kamemoto to VP, Regulatory Affairs. … [Read more...] about Promotions at Alexza

Indian pharmaceutical company Cipla has hired former Teva vice-president Frank Pieters as Head of European Business and Head of Global Respiratory Business. Pieters was most recently Senior VP for the Region of Southern Europe at Teva. Cipla manufactures a wide range of inhaled medications. A recent article in the Business Standard quotes Cipla CFO S Radhakrishnan … [Read more...] about Cipla hires Frank Pieters to head respiratory business

Insmed Incorporated, which is developing Arikace liposomal amikacin for inhalation, has appointed Donald J. Hayden, Jr. as Executive Chairman of its Board of Directors, effective immediately. He has been serving as Chairman of the board of directors since the end of 2010 when Insmed merged with Transave, and he will continue to focus on the development of Arikace … [Read more...] about Insmed appoints Donald J. Hayden, Jr. as Executive Chairman of the Board of Directors

Mark Shepherd, Respiratory Physics Lab and Workshop Manager at Team Consulting, will attempt to set a world record by climbing to the top of the Empire State Building in New York City while carrying 125 kg on his back. The attempt will take place on May 26, 2012 and will benefit the Myositis Support Group, a UK charity. To date, Shepherd has raised £370,000 through … [Read more...] about OINDP specialist Mark Shepherd to attempt world record

The University of Western Ontario has named particle technology researcher Jesse Zhu a 2012 Distinguished University Professorship winner. Zhu, a professor and Canada Research Chair in Powder Technology Applications in the Department of Chemical and Biochemical Engineering at Western, has published a number of papers related to dry powder inhalation. Zhu has been … [Read more...] about Jesse Zhu wins Distinguished University Professorship

Hovione has appointed Colin Minchom, formerly Patheon's VP of Pharmaceutical Development Services for North America, as VP of its Particle Design Business Unit. Minchom has almost 30 years experience in drug development, especially in dosage forms and delivery, and is a member of the USP expert committee on small molecules. He is also chair of the planning committee … [Read more...] about Hovione hires Colin Minchom as VP of its particle design business unit